Upper airway obstructive disease in mucopolysaccharidoses: Polysomnography, computed tomography and nasal endoscopy findings
- 14 June 2007
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 30 (5) , 743-749
Abstract
Summary: In mucopolysaccharidoses, upper airway obstruction has multiple causative factors and progressive respiratory disease may severely affect morbidity and mortality. In a cross‐sectional study over 2 years we evaluated upper airway obstructive disease through overnight polysomnography, upper airway computed tomography and nasal endoscopy in 5 children and 6 adults with mucopolysaccharidoses of various types. Measurements of apnoea and apnoea‐hypopnoea index, arousal index, and sleep efficiency were obtained through polysomnography. Retropalatal and retroglossal spaces were calculated through computed tomography, and the degree of adenoid hypertrophy was assessed through endoscopy. Apnoea index and apnoea‐hypopnoea index were significantly higher in children than in adults with mucopolysaccharidoses (p=.03 and p=03, respectively). Compared to healthy controls, retropalatal and retroglossal spaces were significantly smaller in children (p=03 and p=.004, respectively) or adults with mucopolysaccharidoses (p=.004 and p=.004, respectively). All subjects had adenoid hypertrophy causing first‐degree (36%) or second‐degree (64%) obstruction at endoscopy. Overnight polysomnography, upper airway computed tomography and nasal endoscopy are useful tools for diagnosing obstructive sleep apnoea syndrome in mucopolysaccharidoses, and identifying the site and severity of airway obstruction.Keywords
This publication has 32 references indexed in Scilit:
- Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyThe Journal of Pediatrics, 2006
- The first 5years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis IExpert Opinion on Pharmacotherapy, 2005
- Using imaging biomarkers to accelerate drug development and clinical trialsDrug Discovery Today, 2005
- Treatment of respiratory system (not just lung!) abnormalities in Mucopolysaccharidosis IThe Journal of Pediatrics, 2004
- The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentationsThe Journal of Pediatrics, 2004
- Upper airways abnormalities and tracheal problems in Morquio's diseaseThorax, 2003
- Estimating cancer risks from pediatric CT: going from the qualitative to the quantitativePediatric Radiology, 2002
- Hunter′s syndrome and associated sleep apnoea cured by CPAP and surgeryEuropean Respiratory Journal, 1999
- Severe Type Hunter's Syndrome. Polysomnographic and Neuropathological StudyNeuropediatrics, 1992
- Sleep apnoea in Scheie's syndrome.Thorax, 1980